| abstract |
The present invention relates to a method for preventing, treating or inhibiting tumor development and / or metastasis in a subject. An immunomodulator for use in the treatment, reduction, inhibition, or control of a neoplastic disease in a patient who is scheduled to receive simultaneous, separate or sequential checkpoint inhibition therapy upon administration of the immunomodulatory agent. The immunomodulator is preferably a whole cell mycobacterium such as M. pneumoniae. vaccae or M.I. includes objense. [Selection figure] None |